GRI Bio, Inc. financial data

Symbol
GRI on Nasdaq
Location
La Jolla, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 209% % -11%
Debt-to-equity 92% % 22%
Return On Equity -426% % -47%
Return On Assets -222% % -35%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,268,727 shares -63%
Common Stock, Shares, Outstanding 3,268,727 shares -35%
Entity Public Float $1,500,000 USD -84%
Weighted Average Number of Shares Outstanding, Basic 2,621,498 shares 1310%
Weighted Average Number of Shares Outstanding, Diluted 2,621,498 shares 1310%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $6,121,000 USD 54%
General and Administrative Expense $5,145,000 USD 19%
Operating Income (Loss) $11,266,000 USD -36%
Net Income (Loss) Attributable to Parent $11,244,000 USD -36%
Earnings Per Share, Basic 110 USD/shares 89%
Earnings Per Share, Diluted 110 USD/shares 89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,055,000 USD -15%
Assets, Current $4,697,000 USD -12%
Property, Plant and Equipment, Net $1,000 USD -80%
Operating Lease, Right-of-Use Asset $84,000 USD -36%
Assets $4,782,000 USD -12%
Accounts Payable, Current $1,317,000 USD 16%
Employee-related Liabilities, Current $504,000 USD 79%
Accrued Liabilities, Current $1,388,000 USD 161%
Liabilities, Current $2,759,000 USD 61%
Operating Lease, Liability, Noncurrent $30,000 USD -64%
Liabilities $2,789,000 USD 55%
Retained Earnings (Accumulated Deficit) $49,037,000 USD -30%
Stockholders' Equity Attributable to Parent $1,993,000 USD -46%
Liabilities and Equity $4,782,000 USD -12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,736,000 USD 21%
Net Cash Provided by (Used in) Financing Activities $11,000 USD -100%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 3,268,727 shares -35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,747,000 USD -177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,055,000 USD -15%
Deferred Tax Assets, Valuation Allowance $16,684,000 USD 15%
Deferred Tax Assets, Gross $16,684,000 USD 15%
Operating Lease, Liability $119,000 USD 750%
Depreciation $4,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid $137,000 USD 879%
Property, Plant and Equipment, Gross $34,000 USD 0%
Operating Lease, Liability, Current $54,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $62,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $60,000 USD 329%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $18,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $15,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $14,537,000 USD 13%
Share-based Payment Arrangement, Expense $763,000 USD 419%